Combined therapy for thyroid squamous cell carcinoma
Head and Neck Oncology , Volume 34 - Issue 1 p. 131- 134
Background. Squamous carcinoma of the thyroid is a rare aggressive disease, resulting in poor prognosis. Methods. and Results. We combined cisplatin with paclitaxel on a weekly basis as induction therapy, achieving a high cumulative dose, in a patient with squamous cell tumor of the thyroid with arterial encasement. After surgery, pathologic examination confirmed a complete resection of the primary tumor with clear margins, revealing a successful induction treatment with chemotherapy. Conclusions. Our patient now has a recurrence-free survival of >20 months, longer than the mean survival described in the literature.
|, , , ,|
|Head and Neck Oncology|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
de Vos, F.Y.F.L, Sewnaik, A, de Wilt, J.H.W, Smid, E.J, den Bakker, M.A, & van Meerten, E. (2012). Combined therapy for thyroid squamous cell carcinoma. Head and Neck Oncology, 34(1), 131–134. doi:10.1002/hed.21484